Design, Synthesis, and Antitumor Activity of Ergosterol Peroxide Hydrogen Sulfide Donor Derivatives
- 20 July 2026
- journal article
- research article
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (8) , 233
Abstract
Hydrogen sulfide has been recognized as an effective endogenous signaling gasotransmitter, and exhibits antiproliferative activity against several cancer cells. To improve the antitumor activity of ergosterol peroxide (EP), a series of ergosterol peroxide hydrogen sulfide donor derivatives were synthesized by conjugating EP with an H2S-donating compound ADT-OH [5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione]. Most derivatives showed more potent antiproliferative activities than EP against A549 and HepG2 cell lines, while they were lack of sensitivity to MCF-7 cells. In particular, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate showed the most potent antiproliferative activities against A549 cells with IC50 value of 2.52 μM, which demonstrated 7.4-fold improvement comparing to the parent compound EP. In the H2S release experiment, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was able to release a greater amount of H2S and reached its maximum value within 15 min. (3β,5α,8α,22E)-5,8-Epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was also found have a strong binding affinity (–9.1 kcal/mol) with ATP-binding pocket of epidermal growth factor receptor (EGFR) protein. Additionally, the results of ADMET predictions suggested that these compounds possess favorable drug-like properties and good membrane permeability. The above findings indicate that this compound may become a highly promising lead compound for the development of anti-non-small cell lung cancer drugs.Keywords
This publication has 46 references indexed in Scilit:
- Cancer of the ovary, fallopian tube, and peritoneum: 2025 updateInternational Journal of Gynecology & Obstetrics, 2025
- Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathwayBioorganic & Medicinal Chemistry, 2024
- Design and synthesis of novel mitochondria-targeted ergosterol peroxide derivatives as potential anti-cancer agentsBioorganic Chemistry, 2024
- S-Allyl-L-cysteine (SAC) inhibits copper-induced apoptosis and cuproptosis to alleviate cardiomyocyte injuryBiochemical and Biophysical Research Communications, 2024
- Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discoveryBioorganic Chemistry, 2023
- ADT‐OH synergistically enhanced the antitumor activity of celecoxib in human colorectal cancer cellsCancer Medicine, 2023
- Modulation of acid-sensing ion channels by hydrogen sulfideBiochemical and Biophysical Research Communications, 2020
- Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular DiseasesCardiovascular Drugs and Therapy, 2020
- A novel hydrogen sulfide-releasing donor, HA-ADT, suppresses the growth of human breast cancer cells through inhibiting the PI3K/AKT/mTOR and Ras/Raf/MEK/ERK signaling pathwaysCancer Letters, 2019
- Sustained Release of Hydrogen Sulfide (H2S) from Poly(Lactic Acid) Functionalized 4-Hydroxythiobenzamide Microparticles to Protect Against Oxidative DamageAnnals of Biomedical Engineering, 2019